Arina S. Lazareva

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Journal: Journal of human immunity

Published: April 19, 2026

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Base editing reversal of radiation sensitivity in NHEJ1 immunodeficiency.

Journal: Journal of human immunity

Published: April 19, 2026

Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK study.

Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK study.

Journal: British journal of haematology

Published: January 15, 2026

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.

Journal: Pediatric blood & cancer

Published: January 22, 2024

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.

Journal: Blood advances

Published: July 10, 2023

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

Journal: Blood

Published: March 31, 2023

Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases.

Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases.

Journal: Bone marrow transplantation

Published: July 21, 2022

CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy.

CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy.

Journal: Blood advances

Published: March 14, 2022

Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.

Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.

Journal: British journal of haematology

Published: July 29, 2021

Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.

Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.

Journal: British journal of haematology

Published: June 04, 2021

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.

Journal: Clinical pharmacology and therapeutics

Published: August 07, 2019

Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources.

Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources.

Journal: Expert review of clinical immunology

Published: May 10, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026